Translational Development Acquisition, ProLogium to Combine in $3.8 Billion Transaction

MT Newswires Live
May 27

Translational Development Acquisition (TDAC), a blank-check company, and ProLogium said Wednesday they have agreed to a business combination valuing ProLogium at about $3.8 billion on a pre-money, net cash-free basis.

ProLogium will seek funding by a combination of Translational's cash in trust and proceeds from a private investment in public equity deal, the companies said.

The boards of both companies have approved the deal, which is set to close in H2 and would result in the combined company ProLogium Technology becoming a Nasdaq-listed company under the ticker symbol PRLG, according to the statement.

The transaction is anticipated to fund the scaling of ProLogium's production of its fourth-generation batteries and the construction of a gigafactory in Dunkirk, France, the companies said.

ProLogium aims to mass produce solid-state battery technology with its proprietary lithium ceramic battery platform, the companies added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10